{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": 1441
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson’s disease. Mutations in LRRK2 reduce its kinase activity towards Akt1, leading to decreased phosphorylation of Akt1 at Ser473, which is important for cell survival and prevention of apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism, focusing on how LRRK2 mutations impair Akt1 phosphorylation and contribute to neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used in vitro kinase assays and GST pull-down assays to assess the interaction and phosphorylation of Akt1 by LRRK2.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the kinase activity of LRRK2 and its interaction with Akt1, which is central to understanding the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls were included, such as wild-type LRRK2 and heat-denatured Akt1. Experiments were performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "The paper states that both wild-type and mutant LRRK2 were used as controls, and experiments were conducted with multiple replicates."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The R1441C mutation exhibited significantly weaker kinase activity towards Akt1(Ser473) phosphorylation compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses showed a significant reduction in Akt1 phosphorylation, supporting the pathogenic nature of the R1441C mutation."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The R1441C mutation in LRRK2 significantly reduces its kinase activity towards Akt1, leading to decreased phosphorylation of Akt1 at Ser473. This supports the pathogenic nature of the variant, as Akt1 phosphorylation is crucial for cell survival and preventing apoptosis."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": 2019
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson’s disease. Mutations in LRRK2 reduce its kinase activity towards Akt1, leading to decreased phosphorylation of Akt1 at Ser473, which is important for cell survival and prevention of apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism, focusing on how LRRK2 mutations impair Akt1 phosphorylation and contribute to neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used in vitro kinase assays and GST pull-down assays to assess the interaction and phosphorylation of Akt1 by LRRK2.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the kinase activity of LRRK2 and its interaction with Akt1, which is central to understanding the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls were included, such as wild-type LRRK2 and heat-denatured Akt1. Experiments were performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "The paper states that both wild-type and mutant LRRK2 were used as controls, and experiments were conducted with multiple replicates."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The G2019S mutation exhibited significantly weaker kinase activity towards Akt1(Ser473) phosphorylation compared to wild-type LRRK2, despite having hyperkinase activity towards MBP.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses showed a significant reduction in Akt1 phosphorylation, supporting the pathogenic nature of the G2019S mutation."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The G2019S mutation in LRRK2 significantly reduces its kinase activity towards Akt1, leading to decreased phosphorylation of Akt1 at Ser473. Despite its hyperkinase activity towards MBP, this supports the pathogenic nature of the variant, as Akt1 phosphorylation is crucial for cell survival and preventing apoptosis."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": 2020
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson’s disease. Mutations in LRRK2 reduce its kinase activity towards Akt1, leading to decreased phosphorylation of Akt1 at Ser473, which is important for cell survival and prevention of apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism, focusing on how LRRK2 mutations impair Akt1 phosphorylation and contribute to neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used in vitro kinase assays and GST pull-down assays to assess the interaction and phosphorylation of Akt1 by LRRK2.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the kinase activity of LRRK2 and its interaction with Akt1, which is central to understanding the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls were included, such as wild-type LRRK2 and heat-denatured Akt1. Experiments were performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "The paper states that both wild-type and mutant LRRK2 were used as controls, and experiments were conducted with multiple replicates."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The I2020T mutation exhibited significantly weaker kinase activity towards Akt1(Ser473) phosphorylation compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses showed a significant reduction in Akt1 phosphorylation, supporting the pathogenic nature of the I2020T mutation."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The I2020T mutation in LRRK2 significantly reduces its kinase activity towards Akt1, leading to decreased phosphorylation of Akt1 at Ser473. This supports the pathogenic nature of the variant, as Akt1 phosphorylation is crucial for cell survival and preventing apoptosis."
    }
  ]
}